New Cream Promises Female Arousal Boost

A new prescription cream, Dare to Play, has been introduced in the United States, utilizing sildenafil, the same active ingredient found in Viagra. This topical treatment is specifically formulated to enhance physical sexual arousal in women by promoting increased blood flow to the genital tissues. The cream is designed for direct application, aiming to improve sensation, warmth, swelling, and lubrication, which are key physical responses associated with arousal.

Clinical trials conducted by Daré Bioscience indicated improvements in arousal, desire, and orgasm when compared to a placebo. Notably, the studies reported no significant adverse side effects. This innovative approach allows sildenafil to act locally, avoiding the systemic effects that a pill form might entail, which would necessitate higher doses for women.

Women in several US states can now pre-order this compounded prescription cream, with nationwide availability anticipated in early 2026. Daré Bioscience is pursuing full FDA approval and plans a larger Phase 3 clinical trial. This development aims to provide women with a scientifically backed treatment option, comparable to the impact Viagra had for men.